Background: Although the pathogenesis of non‐alcoholic fatty liver disease (NAFLD)
remains poorly understood, metabolic syndrome associated with insulin resistance is the …

AIM: To study the expression of peroxisome proliferator activated receptor-γ (PPARγ) in the
liver of rats with fatty liver disease (FLD) and to explore the role of PPARγ in the …

Abstract Background and Aims: In a previous study, the authors found that reduced
expression of peroxisome proliferator‐activated receptor (PPAR)‐α might play an important …

Objective To identify differences in the expression of peroxisome proliferator-activated
receptor alpha (PPARα) target genes in human peripheral blood mononuclear cells …

Alcoholic liver disease (ALD) is a progressively aggravated liver disease with high incidence
in alcoholics. Ethanol-induced fat accumulation and the subsequent lipopolysaccharide …

Lately, the world has faced tremendous progress in the understanding of non-alcoholic fatty
liver disease (NAFLD) pathogenesis due to rising obesity rates. Peroxisome proliferator …

Peroxisome proliferator-activated receptor α (PPARα) is a ligand-activated transcription
factor belonging, together with PPARγ and PPARβ/δ, to the NR1C nuclear receptor …

Background The peroxisome proliferator activated receptor-gamma (PPARG) is a nuclear
receptor that regulates adipocyte differentiation, insulin sensitivity and lipid metabolism …

Peroxisome proliferator-activated receptor (PPAR) and retinoid x receptor (RXR) play
important roles in fatty acid metabolism. The present study examined the regulation of …

See Article on Page 972. atty liver disease (FLD), which is emerging as the most common
liver disease in clinical practice, is F etiologically diverse and encompasses a morphological …